TEVA - Company ID 0000818686
The table below shows TEVA PHARMACEUTICAL INDUSTRIES LTD's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.56B | $3.30B | $3.23B | $2.80B | $2.17B | $2.18B |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $3.71B | $3.06B | $3.41B | $3.70B | $4.53B | $4.58B |
| Inventory | $3.18B | $3.01B | $4.02B | $3.83B | $3.82B | $4.40B |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $13.95B |
| $12.55B |
| $12.48B |
| $12.05B |
| $12.57B |
| $13.01B |
| Property, plant & equipment | $4.08B | $4.58B | $5.75B | $5.74B | $5.98B | $6.30B |
| Goodwill | $16.00B | $15.15B | $17.18B | $17.63B | $20.04B | $20.62B |
| Total assets | $40.75B | $39.33B | $43.48B | $44.01B | $47.67B | $50.64B |
| Accounts payable | $225.00M | $158.00M | - | - | - | - |
| Total current liabilities | $13.46B | $12.80B | $12.25B | $11.47B | $11.03B | $13.16B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $32.83B | $33.61B | $35.35B | $35.31B | $36.42B | $39.58B |
| Retained earnings | -$13.76B | -$15.17B | -$13.53B | -$12.88B | -$10.53B | -$10.95B |
| Total equity | $7.91B | $5.37B | $7.51B | $7.90B | $10.28B | $10.03B |